TORONTO, Sept. 28, 2017 /PRNewswire/ -- Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced publication of a new CEO letter to the Company's shareholders, providing an update on corporate developments and business strategy. As outlined in the letter, Ehave has established and is executing on key partnerships that allow the company to generate revenue while demonstrating its utility for mental health researchers, pharmaceutical companies and clinicians, setting Ehave on a strong growth trajectory. Interested parties can access the full letter on the Company's website at: https://www.ehave.com/about/shareholder-letter.

"Ehave has made a great deal of strategic and tactical progress this year toward fulfilling our vision to transform mental healthcare, and are excited to provide this context for our announcements" stated Prateek Dwivedi, President and CEO of Ehave. "Since our last update, we've established and expanded the commitments to our mental health (Multi Health Systems) and therapeutic (MedReleaf TSX: LEAF) partners, and entered into new partnerships to expand our market verticals to include the pharmaceutical industry (Aequus TSX-V: AQS). Meanwhile, we are preparing for our next set of trials of our new video games for assessment & remediation of ADD/ADHD developed in collaboration with The Hospital for Sick Children in Toronto. Separately and together, these partnerships will demonstrate the versatility and depth of our platform, which will drive value going forward."

About Ehave, Inc.
Ehave is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis and treatment. With Ehave Connect, Ehave's mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems ("MHS"), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder ("ADHD"), through its collaboration with the Hospital for Sick Children ("SickKids"). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with MedReleaf. For more information, visit https://www.ehave.com/.

Contacts
Tiberend Strategic Advisors, Inc.
Joshua Drumm, Ph.D. (Investors)
(212) 375-2664
[email protected]

Janine McCargo (Media)
646-604-5150
[email protected]

View original content:http://www.prnewswire.com/news-releases/ehave-highlights-recent-developments-and-corporate-strategy-in-updated-letter-to-shareholders-300527249.html

SOURCE Ehave, Inc.